Amiodarone is a widely used antiarrhythmic agent. Among its various
adverse effects,
amiodarone-induced pulmonary
toxicity (APT) is the most
life threatening complication, which has been described mostly in
patients who have been in
treatment with high accumulative doses for a long duration of
time. However,
amiodarone therapy in short-term duration induced APT was rarely reported. We describe a case of a 54-year-old man
who is presented with symptoms of APT after a few days of
therapy for post-
myocardial infarction ventricular tachycardia. For
early diagnosis and successful
treatment,
awareness and high suspicion of this rare type of early onset APT is crucial in
patients with
amiodarone therapy.